A detailed history of Charles Schwab Investment Management Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 648,652 shares of DYN stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
648,652
Previous 601,062 7.92%
Holding current value
$15.5 Million
Previous $21.2 Million 9.84%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$31.94 - $47.04 $1.52 Million - $2.24 Million
47,590 Added 7.92%
648,652 $23.3 Million
Q2 2024

Aug 12, 2024

BUY
$23.65 - $35.63 $3.3 Million - $4.97 Million
139,540 Added 30.23%
601,062 $21.2 Million
Q1 2024

May 08, 2024

BUY
$13.06 - $29.18 $1.7 Million - $3.79 Million
129,954 Added 39.19%
461,522 $13.1 Million
Q4 2023

Feb 06, 2024

BUY
$6.62 - $13.64 $41,024 - $84,527
6,197 Added 1.9%
331,568 $4.41 Million
Q3 2023

Nov 08, 2023

BUY
$8.6 - $12.18 $346,150 - $490,245
40,250 Added 14.12%
325,371 $2.92 Million
Q2 2023

Aug 09, 2023

BUY
$8.53 - $14.28 $490,790 - $821,628
57,537 Added 25.28%
285,121 $3.21 Million
Q1 2023

May 11, 2023

SELL
$10.88 - $15.0 $6,071 - $8,370
-558 Reduced 0.24%
227,584 $2.62 Million
Q4 2022

Feb 13, 2023

BUY
$9.37 - $13.8 $53,483 - $78,770
5,708 Added 2.57%
228,142 $2.64 Million
Q3 2022

Nov 14, 2022

BUY
$7.2 - $15.17 $311,623 - $656,572
43,281 Added 24.16%
222,434 $2.83 Million
Q2 2022

Aug 15, 2022

SELL
$4.36 - $10.5 $58,092 - $139,902
-13,324 Reduced 6.92%
179,153 $1.23 Million
Q1 2022

May 13, 2022

BUY
$6.52 - $12.27 $25,545 - $48,073
3,918 Added 2.08%
192,477 $1.86 Million
Q4 2021

Feb 11, 2022

BUY
$11.89 - $16.07 $52,030 - $70,322
4,376 Added 2.38%
188,559 $2.24 Million
Q3 2021

Nov 16, 2021

BUY
$15.6 - $21.46 $507,889 - $698,673
32,557 Added 21.47%
184,183 $2.99 Million
Q2 2021

Aug 16, 2021

BUY
$15.94 - $22.33 $464,395 - $650,562
29,134 Added 23.78%
151,626 $3.19 Million
Q1 2021

May 17, 2021

BUY
$14.0 - $29.3 $563,024 - $1.18 Million
40,216 Added 48.88%
122,492 $1.9 Million
Q4 2020

Feb 16, 2021

BUY
$16.81 - $23.94 $1.38 Million - $1.97 Million
82,276 New
82,276 $1.73 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.